GINKGO BIOWORKS HOLDINGS INC

Coen Steven P. buys Ginkgo Bioworks shares amid a 43% year‑to‑date decline, signaling insider confidence in its synthetic‑biology platform and a potential short‑term rebound.

Ginkgo Bioworks insiders buy 25k RSUs, signaling confidence in the new board‑aligned compensation plan and future growth prospects.

Insider buying shows Ginkgo Bioworks’ confidence: Coen Steven P.’s recent purchases signal optimism amid rising stock momentum, yet investors should watch earnings and regulatory milestones closely.

Ginkgo Bioworks CFO’s fresh share purchase signals strong insider confidence—insight into how insider buying aligns with cash‑flow targets and future growth prospects.

Coen Steven P.’s recent purchase of 1,174 Ginkgo Bioworks shares, amid a 27.9% price decline, shows steady insider confidence and routine RSU‑related equity management.